Merck & Co Inc

MRK

Company Profile

  • Business description

    Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

  • Contact

    126 East Lincoln Avenue
    RahwayNJ07065
    USA

    T: +1 908 740-4000

    E: [email protected]

    https://www.merck.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    75,000

Merck & Co Inc News & Analysis

markets

Market Minute: Trade policy dominates, opportunities in global healthcare, and a local rate cut on the cards

Senior Portfolio Manager Bryce Anderson reviews the biggest market movements of the week, with Trump’s trade policy dominating again.
stocks

The 10 best US dividend stocks

These are the top dividend-paying stocks to buy in 2025.
stocks

The 10 best US dividend stocks

These undervalued stocks with reliable dividends are worth considering.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,140.5011.000.12%
CAC 407,674.7824.14-0.31%
DAX 4023,596.98173.35-0.73%
Dow JONES (US)45,357.82263.47-0.58%
FTSE 1009,208.218.66-0.09%
HKSE25,417.98359.471.43%
NASDAQ21,661.6746.03-0.21%
Nikkei 22543,018.75438.481.03%
NZX 50 Index13,223.5390.330.69%
S&P 5006,470.2131.87-0.49%
S&P/ASX 2008,871.208.600.10%
SSE Composite Index3,812.5146.641.24%

Market Movers